Compositions and methods for inhibiting the biological activity of soluble biomolecules
The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. Also provided herein are a number of applications (e.g., therapeutic applications) in which the compositions are useful.
1. A particle having at least one surface, an agent immobilized on the surface, and a coating immobilized on the surface, wherein:
the agent immobilized on the surface selectively binds to a target that is a first member of a specific binding pair;
binding of the target to the agent immobilized on the surface inhibits the interaction of the target with a second member of the specific binding pair;
the target is a soluble biomolecule, and
the coating inhibits interactions between the agent immobilized on the surface and molecules on a cell surface.
2. The particle of claim 1 , wherein the target is a form of a cell surface protein.
3. The particle of claim 1 , wherein the target is a ligand for a cell surface receptor.
4. The particle of claim 1 , wherein the target is a ligand for a cytosolic receptor or a nuclear receptor.
5. The particle of claim 1 , wherein the target is a cytokine, chemokine or enzyme.
6. The particle of claim 5 , wherein the cytokine, chemokine or enzyme is expressed by a cancer cell.
7. The particle of claim 1 , wherein the target is a small molecule, an antibody, a toxin or a viral protein.
8. The particle of claim 1 , wherein the agent is a small molecule, a macrocycle compound, a polypeptide, a protein, a peptide, a peptidomimetic compound, a nucleic acid, or a nucleic acid analog.
9. The particle of claim 8 , wherein the agent is a ligand of a cell surface receptor protein.
10. The particle of claim 9 , wherein the agent is a natural ligand of a cell surface receptor protein.
11. The particle of claim 8 , wherein the agent is an antibody or a biomolecule-binding fragment of an antibody.
12. The particle of claim 11 , wherein the antibody or a biomolecule-binding fragment of an antibody is an antibody or a biomolecule-binding fragment of an antibody to a soluble tumor necrosis factor receptor protein, a toxin, or a viral protein.
13. The particle of claim 12 , wherein the antibody or a biomolecule-binding fragment of an antibody is an antibody or a biomolecule-binding fragment of an antibody to a soluble tumor necrosis factor receptor protein.
14. The particle of claim 1 , wherein the coating comprises a plurality of coating moieties or coating molecules on a surface of the particle, and the plurality of coating molecules inhibits interactions between the agent and molecules on a cell surface.
15. The particle of claim 14 , wherein the plurality of coating moieties or coating molecules is bound to a surface of the particle.
16. The particle of claim 14 , wherein the agent is a small molecule, a macrocycle compound, a polypeptide, a protein, a peptide, a peptidomimetic compound, a nucleic acid, or a nucleic acid analog.
17. The particle of claim 16 , wherein the agent is a ligand of a cell surface receptor protein.
18. The particle of claim 16 , wherein the agent is an antibody or a biomolecule-binding fragment of an antibody.
19. The particle of claim 18 , wherein the antibody or a biomolecule-binding fragment of an antibody is an antibody or a biomolecule-binding fragment of an antibody to a soluble tumor necrosis factor receptor protein, a toxin, or a viral protein.
20. The particle of claim 19 , wherein the antibody or a biomolecule-binding fragment of an antibody is an antibody or a biomolecule-binding fragment of an antibody to a soluble tumor necrosis factor receptor protein.